Skip to main content
NCBI home page
Philosophical Transactions of the Royal Society B: Biological Sciences logoLink to Philosophical Transactions of the Royal Society B: Biological Sciences
. 1997 Sep 29;352(1359):1303–1310. doi: 10.1098/rstb.1997.0114

Why intracellular parasitism need not be a degrading experience for Mycobacterium.

D G Russell 1, S Sturgill-Koszycki 1, T Vanheyningen 1, H Collins 1, U E Schaible 1
PMCID: PMC1692028  PMID: 9355121

Abstract

The success of mycobacteria as pathogens hinges on their ability to infect and persist within the macrophages of their host. However, activation of host macrophages by cytokines from a productive cellular immune response can stimulate the cells to kill their resident pathogens. This suggests that the interaction between host cell and microbe is in delicate balance, which can be tipped in favour of either organism. Biochemical analysis of mycobacterial vacuoles has shown them to be integral to the host cell's recycling endosomal system. As such they show limited acidification and hydrolytic activity despite possession of known lysosomal constituents such as cathepsins D, B and L, and LAMP 1. Even in established infections, they remain dynamic compartments accessible to several plasmalemma-derived constituents. Once the macrophage has been activated by IFN-gamma and TNF-alpha the vacuoles coalesce and acidify. This marks a distinct alteration in vacuole physiology and leads to stasis and death of the mycobacteria. Mycobacteria have developed several strategies to avoid this outcome. Most notably, live bacilli-induce sustained release of IL-6 from infected macrophages. IL-6 blocks the ability of both polyclonal primary T cells and T-cell hybridomas to respond to appropriate stimuli. Such an activity could render the centres of infection foci, such as granulomas, anergic and thus avoid release of macrophage-activating cytokines. This paper discusses both the mechanisms by which mycobacteria try to ensure their success as intracellular pathogens and the relevance of these strategies to the overall understanding of mycobacterial diseases.

Full Text

The Full Text of this article is available as a PDF (194.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong J. A., Hart P. D. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med. 1975 Jul 1;142(1):1–16. doi: 10.1084/jem.142.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Armstrong J. A., Hart P. D. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med. 1971 Sep 1;134(3 Pt 1):713–740. doi: 10.1084/jem.134.3.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bermudez L. E. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide. Clin Exp Immunol. 1993 Feb;91(2):277–281. doi: 10.1111/j.1365-2249.1993.tb05895.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Britton W. J. Immunology of leprosy. Trans R Soc Trop Med Hyg. 1993 Sep-Oct;87(5):508–514. doi: 10.1016/0035-9203(93)90066-y. [DOI] [PubMed] [Google Scholar]
  5. Champsi J., Young L. S., Bermudez L. E. Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection. Immunology. 1995 Apr;84(4):549–554. [PMC free article] [PubMed] [Google Scholar]
  6. Chan J., Tanaka K., Carroll D., Flynn J., Bloom B. R. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun. 1995 Feb;63(2):736–740. doi: 10.1128/iai.63.2.736-740.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clemens D. L., Horwitz M. A. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med. 1995 Jan 1;181(1):257–270. doi: 10.1084/jem.181.1.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clemens D. L., Horwitz M. A. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J Exp Med. 1996 Oct 1;184(4):1349–1355. doi: 10.1084/jem.184.4.1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Colizzi V., Ferluga J., Garreau F., Malkovsky M., Asherson G. L. Suppressor cells induced by BCG release non-specific factors in vitro which inhibit DNA synthesis and interleukin-2 production. Immunology. 1984 Jan;51(1):65–71. [PMC free article] [PubMed] [Google Scholar]
  10. Dautry-Varsat A., Ciechanover A., Lodish H. F. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2258–2262. doi: 10.1073/pnas.80.8.2258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Desjardins M., Huber L. A., Parton R. G., Griffiths G. Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J Cell Biol. 1994 Mar;124(5):677–688. doi: 10.1083/jcb.124.5.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Frehel C., de Chastellier C., Lang T., Rastogi N. Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Infect Immun. 1986 Apr;52(1):252–262. doi: 10.1128/iai.52.1.252-262.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hanano R., Kaufmann S. H. Nitric oxide production and mycobacterial growth inhibition by murine alveolar macrophages: the sequence of rIFN-gamma stimulation and Mycobacterium bovis BCG infection determines macrophage activation. Immunol Lett. 1995 Feb;45(1-2):23–27. doi: 10.1016/0165-2478(94)00193-u. [DOI] [PubMed] [Google Scholar]
  14. Hastings R. C., Gillis T. P., Krahenbuhl J. L., Franzblau S. G. Leprosy. Clin Microbiol Rev. 1988 Jul;1(3):330–348. doi: 10.1128/cmr.1.3.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hirano T. Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol. 1992 Jan;62(1 Pt 2):S60–S65. doi: 10.1016/0090-1229(92)90042-m. [DOI] [PubMed] [Google Scholar]
  16. Kaplan G. Recent advances in cytokine therapy in leprosy. J Infect Dis. 1993 Mar;167 (Suppl 1):S18–S22. doi: 10.1093/infdis/167.supplement_1.s18. [DOI] [PubMed] [Google Scholar]
  17. Law K., Weiden M., Harkin T., Tchou-Wong K., Chi C., Rom W. N. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med. 1996 Feb;153(2):799–804. doi: 10.1164/ajrccm.153.2.8564135. [DOI] [PubMed] [Google Scholar]
  18. Lemaire I., Yang H., Lafont V., Dornand J., Commes T., Cantin M. F. Differential effects of macrophage- and granulocyte-macrophage colony-stimulating factors on cytokine gene expression during rat alveolar macrophage differentiation into multinucleated giant cells (MGC): role for IL-6 in type 2 MGC formation. J Immunol. 1996 Dec 1;157(11):5118–5125. [PubMed] [Google Scholar]
  19. Mellman I. The importance of being acid: the role of acidification in intracellular membrane traffic. J Exp Biol. 1992 Nov;172:39–45. doi: 10.1242/jeb.172.1.39. [DOI] [PubMed] [Google Scholar]
  20. Nash D. R., Douglass J. E. Anergy in active pulmonary tuberculosis. A comparison between positive and negative reactors and an evaluation of 5 TU and 250 TU skin test doses. Chest. 1980 Jan;77(1):32–37. doi: 10.1378/chest.77.1.32. [DOI] [PubMed] [Google Scholar]
  21. O'Brien L., Roberts B., Andrew P. W. In vitro interaction of Mycobacterium tuberculosis and macrophages: activation of anti-mycobacterial activity of macrophages and mechanisms of anti-mycobacterial activity. Curr Top Microbiol Immunol. 1996;215:97–130. doi: 10.1007/978-3-642-80166-2_5. [DOI] [PubMed] [Google Scholar]
  22. Pancholi P., Mirza A., Bhardwaj N., Steinman R. M. Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages. Science. 1993 May 14;260(5110):984–986. doi: 10.1126/science.8098550. [DOI] [PubMed] [Google Scholar]
  23. Rijnboutt S., Stoorvogel W., Geuze H. J., Strous G. J. Identification of subcellular compartments involved in biosynthetic processing of cathepsin D. J Biol Chem. 1992 Aug 5;267(22):15665–15672. [PubMed] [Google Scholar]
  24. Russell D. G., Dant J., Sturgill-Koszycki S. Mycobacterium avium- and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma. J Immunol. 1996 Jun 15;156(12):4764–4773. [PubMed] [Google Scholar]
  25. Sibley L. D., Franzblau S. G., Krahenbuhl J. L. Intracellular fate of Mycobacterium leprae in normal and activated mouse macrophages. Infect Immun. 1987 Mar;55(3):680–685. doi: 10.1128/iai.55.3.680-685.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sturgill-Koszycki S., Schaible U. E., Russell D. G. Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J. 1996 Dec 16;15(24):6960–6968. [PMC free article] [PubMed] [Google Scholar]
  27. Sturgill-Koszycki S., Schlesinger P. H., Chakraborty P., Haddix P. L., Collins H. L., Fok A. K., Allen R. D., Gluck S. L., Heuser J., Russell D. G. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science. 1994 Feb 4;263(5147):678–681. doi: 10.1126/science.8303277. [DOI] [PubMed] [Google Scholar]
  28. VanHeyningen T. K., Collins H. L., Russell D. G. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. J Immunol. 1997 Jan 1;158(1):330–337. [PubMed] [Google Scholar]
  29. Wallis R. S., Ellner J. J. Cytokines and tuberculosis. J Leukoc Biol. 1994 May;55(5):676–681. doi: 10.1002/jlb.55.5.676. [DOI] [PubMed] [Google Scholar]
  30. Xu S., Cooper A., Sturgill-Koszycki S., van Heyningen T., Chatterjee D., Orme I., Allen P., Russell D. G. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J Immunol. 1994 Sep 15;153(6):2568–2578. [PubMed] [Google Scholar]
  31. de Chastellier C., Lang T., Thilo L. Phagocytic processing of the macrophage endoparasite, Mycobacterium avium, in comparison to phagosomes which contain Bacillus subtilis or latex beads. Eur J Cell Biol. 1995 Oct;68(2):167–182. [PubMed] [Google Scholar]
  32. van Weert A. W., Dunn K. W., Geuze H. J., Maxfield F. R., Stoorvogel W. Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump. J Cell Biol. 1995 Aug;130(4):821–834. doi: 10.1083/jcb.130.4.821. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Philosophical Transactions of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES